Deferiprone is an orally bioavailable bidentate ligand with iron chelating activity.1 It binds to iron in a 3:1 (ligand:iron) molar ratio and, thereby, is able to remove excess iron from the body. Deferiprone has been investigated for clinical use in diseases of systemic iron overload.
The proportion of deferiprone tablet in 2016 is about 62.64%, while deferiprone capsule have a 26.76% market share.Deferiprone is widely applied in Transfusional Iron Overload and NTDT Caused Iron Overload. The most proportion of deferiprone is Transfusional Iron Overload and in 2016 with 79.42% market
North America is the largest consumption region of deferiprone, with a consumption value market share nearly 28.48% in 2016. Europe is the second largest consumption region of deferiprone, enjoying consumption value market share nearly 24.39% in 2016.Apotex, Cipla and other company are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

Market Analysis and Insights: Global Deferiprone Market
The global Deferiprone market size is projected to reach US$ 37 million by 2026, from US$ 35 million in 2020, at a CAGR of 0.9% during 2021-2026.

Global Deferiprone Scope and Market Size
The global Deferiprone market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Deferiprone market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Deferiprone market is segmented into
Tablet
Oral Solution
Capsule

Segment by Application, the Deferiprone market is segmented into
Transfusional Iron Overload
NTDT Caused Iron Overload

The Deferiprone market is analysed and market size information is provided by regions (countries). Segment by Application, the Deferiprone market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape

and Deferiprone Market Share Analysis
Deferiprone market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Deferiprone business, the date to enter into the Deferiprone market, Deferiprone product introduction, recent developments, etc.

The major vendors covered:
Apotex
Cipla